|
Originally published In Press as doi:10.1074/jbc.M205528200 on January 6, 2003
J. Biol. Chem., Vol. 278, Issue 11, 9235-9243, March 14, 2003
Calcium Induces Cell Survival and Proliferation through the
Activation of the MAPK Pathway in a Human Hormone-dependent
Leukemia Cell Line, TF-1*
Ágota
Apáti ,
Judit
Jánossy§,
Anna
Brózik ,
Pál
Imre
Bauer¶, and
Mária
Magócsi
From the Department of Cell Metabolism, National
Medical Centre, Institute of Haematology and Immunology,
Diószegi út 64, Budapest H-1113, the § Institute
of Enzymology, Hungarian Academy of Sciences, Budapest H-1113, and
the ¶ Department of Medical Biochemistry, Semmelweis University,
Budapest H-1088, Hungary
Survival and proliferation of cells of a human
myelo-erythroid CD34+ leukemia cell line (TF-1) depend on the presence
of granulocyte-macrophage colony-stimulating factor or interleukin-3.
Upon hormone withdrawal these cells stop proliferating and undergo
apoptotic process. In this report we demonstrate that a controlled
increase in [Ca2+]i induces
hormone-independent survival and proliferation of TF-1 cells. We found
that moderate elevation of [Ca2+]i by the
addition of cyclopiasonic-acid protected TF1 cells from apoptosis.
Furthermore, a higher, but transient elevation of
[Ca2+]i by ionomycin treatment induced cell
proliferation. In both cases caspase-3 activity was reduced, and Bcl-2
was up-regulated. Higher elevation of [Ca2+]i by
ionomycin induced MEK-dependent biphasic ERK1/2 activation,
sufficient to move the cells from G0/G1 to S/M
phases. Meanwhile, activation of ERK1/2, phosphorylation of the
Elk-1 transcription factor, and, consequently, a substantial elevation of Egr-1 and c-Fos levels and AP-1 DNA binding were observed. Moderate
elevation of [Ca2+]i, on the other hand, caused a
delayed monophasic activation of ERK1/2 and Elk-1 that was accompanied
with only a small increase of Egr-1 and c-Fos levels and AP-1 DNA
binding. The specific MEK-1 kinase inhibitor, PD98059, inhibited all
the effects of increasing [Ca2+]i, indicating
that the MAPK/ERK pathway activation is essential for TF-1 cell
survival and proliferation. Based on these results we suggest that the
elevation of the [Ca2+]i may influence the
cytokine dependence of hemopoietic progenitors and may contribute to
pathological hematopoiesis.
*
This work was supported by the Hungarian Research
Foundation (Grant OTKA T029291) by the Scientific Research Council,
Ministry of Health (Grant ETT 206/2001), and by NRDP 1/024,
Ministry of Education, Hungary.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel./Fax:
36-1-372-4353; E-mail: magocsi@biomembrane.hu.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. M. Monick, L. S. Powers, C. W. Barrett, S. Hinde, A. Ashare, D. J. Groskreutz, T. Nyunoya, M. Coleman, D. R. Spitz, and G. W. Hunninghake
Constitutive ERK MAPK Activity Regulates Macrophage ATP Production and Mitochondrial Integrity
J. Immunol.,
June 1, 2008;
180(11):
7485 - 7496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zhang, I. Hirschler-Laszkiewicz, Q. Tong, K. Conrad, S.-C. Sun, L. Penn, D. L. Barber, R. Stahl, D. J. Carey, J. Y. Cheung, et al.
TRPM2 is an ion channel that modulates hematopoietic cell death through activation of caspases and PARP cleavage
Am J Physiol Cell Physiol,
April 1, 2006;
290(4):
C1146 - C1159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Kitsos, U. Sankar, M. Illario, J. M. Colomer-Font, A. W. Duncan, T. J. Ribar, T. Reya, and A. R. Means
Calmodulin-dependent Protein Kinase IV Regulates Hematopoietic Stem Cell Maintenance
J. Biol. Chem.,
September 30, 2005;
280(39):
33101 - 33108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. B. Elkind, Z. Szentpetery, A. Apati, C. Ozvegy-Laczka, G. Varady, O. Ujhelly, K. Szabo, L. Homolya, A. Varadi, L. Buday, et al.
Multidrug Transporter ABCG2 Prevents Tumor Cell Death Induced by the Epidermal Growth Factor Receptor Inhibitor Iressa (ZD1839, Gefitinib)
Cancer Res.,
March 1, 2005;
65(5):
1770 - 1777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. T. Maliekal, R. J. Anto, and D. Karunagaran
Differential Activation of Smads in HeLa and SiHa Cells That Differ in Their Response to Transforming Growth Factor-{beta}
J. Biol. Chem.,
August 27, 2004;
279(35):
36287 - 36292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Monick, R. K. Mallampalli, M. Bradford, D. McCoy, T. J. Gross, D. M. Flaherty, L. S. Powers, K. Cameron, S. Kelly, A. H. Merrill Jr., et al.
Cooperative Prosurvival Activity by ERK and Akt in Human Alveolar Macrophages is Dependent on High Levels of Acid Ceramidase Activity
J. Immunol.,
July 1, 2004;
173(1):
123 - 135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Paruchuri and A. Sjolander
Leukotriene D4 Mediates Survival and Proliferation via Separate but Parallel Pathways in the Human Intestinal Epithelial Cell Line Int 407
J. Biol. Chem.,
November 14, 2003;
278(46):
45577 - 45585.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|